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Aims Cryothermal energy (CTE) ablation via a balloon catheter (Arctic Front, CryocathTM) represents a novel technology
for pulmonary vein isolation (PVI). However, balloon-based PVI approaches are associated with phrenic nerve palsy
(PNP). We investigated whether ‘single big cryoballoon’-deployed CTE lesions can (i) achieve acute electrical PVI
without left atrium (LA) imaging and (ii) avoid PNP in patients with paroxysmal atrial ﬁbrillation (PAF).
Methods
and results
After double transseptal punctures, one Lasso catheter and a big 28 mm cryoballoon catheter using a steerable sheath
were inserted into the LA. PV angiography and ostial Lasso recordings from all PVs were obtained. Selective PV angio-
graphy was used to evaluate balloon to LA–PV junction contact. CTE ablation lasted 300 s, and the PN was paced
during freezing at right-sided PVs. Twenty-seven patients (19 males, mean age: 56 + 9 years, LA size: 42 + 5 mm)
with PAF (mean duration: 6.6 + 5.7 years) were included. PVI was achieved in 97/99 PVs (98%). Median (Q1; Q3) pro-
cedural, balloon, and ﬂuoroscopy times were 220 min (190; 245), 130 min (90; 170), and 50 min (42; 69), respectively.
Three transient PNP occurred after distal PV ablations. No PV stenosis occurred. Total median (Q1; Q3) follow-up time
was 271 days (147; 356), and 19 of 27 patients (70%) remained in sinus rhythm (3-month blanking period).
Conclusion Using the single big cryoballoon technique, almost all PVs (98%) could be electrically isolated without LA imaging and
may reduce the incidence of PNP as long as distal ablation inside the septal PVs is avoided.
-----------------------------------------------------------------------------------------------------------------------------------------------------------
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Introduction
Muscular sleeves connecting the left atrium (LA) and pulmonary
veins (PVs) can be ablated using either a segmental or a circumfer-
ential approach.
1–3
Success rates for radiofrequency current (RFC) ablation have
improved after the introduction of advanced mapping and ablation
strategies.
3 However, procedural complexity, if the endpoint was
deﬁned as PV isolation and procedure-related complications,
has limited a widespread application.
4–7 Balloon-based catheter
ablation systems have the potential to isolate the PVs with a single
application.
8 Cryothermalenergy(CTE) hasbeenpreviously demon-
stratedtobesafe.
9,10UsingCTEforPVisolation(PVI),noPVstenosis
andalowriskofthrombusformationhavebeenreported.
11,12Thisis
inagreementwithexperimentalanimaldata.
13,14Moreover,PVIusing
the novel cryoballoon (Arctic Front, CryocathTM)c o u l db e
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13 and in humans,
15–18
however, with the use of different cryoballoon sizes and additional
‘touch-up’ freezes (Freezor Max, CryocathTM). Notably, phrenic
nerve palsy (PNP) did occur particularly with the use of small bal-
loons at the right superior PV (RSPV).
15–18
We hypothesized that a cryoballoon-based PVI has the potential
to become a straightforward, simple, and safe ablation procedure
for paroxysmal atrial ﬁbrillation (PAF) if only one ‘single big cryo-
balloon’ is used: (i) to acutely isolate all PVs, (ii) to create lesions at
the antrum level (LA–PV junction), and (iii) to prevent compli-
cations, particularly PNP.
Methods
Inclusion and exclusion criteria
Between April 2006 and May 2007, a total of 27 consecutive patients
with PAF were included in this study and provided written informed
consent. The study subjects met the following inclusion criterion: a
history of highly symptomatic PAF ( 1 episode/week) despite treat-
ment with one or more anti-arrhythmic drugs (AADs), and both inves-
tigators (K.R.J.C. and K.H.K.) were present to perform the procedure.
Exclusion criteria were deﬁned as an LA diameter  55 mm, severe left
ventricular hypertrophy (LV wall thickness  15 mm), LA thrombus,
prior stroke, or decompensated heart failure. Importantly, no cardiac
magnetic resonance imaging (MRI) or computed tomography scan
had been obtained before the procedure. Therefore, no patient was
excluded due to previously known PV anatomy.
Cryoballoon catheter
The cryoballoon catheter (Arctic Front, CryocathTM,2 8m md i a m e t e r ,
10.5 F shaft) consists of an inner and outer lumen. The refrigerant N2O
is delivered into the inner balloon where it undergoes a liquid-to-gas
phasechange,resultinginaninnerballooncoolingtemperatureofapproxi-
mately 2808C.Thecatheterisequippedwithcentrallumina,whichisused
for(i)theinsertionoftheguidewire(Amplatzstiffwire)and(ii)injectionof
contrast medium (diluted 1:1 ratio with 0.9% saline) for PV angiograms.
Using the ‘over-the-wire’ technique in conjunction with the steerable
sheath (12 F, FlexCath, CryocathTM) ,t h eb a l l o o nc a nb en a v i g a t e dt o
each PV ostium. In addition, the cryoballoon itself is steerable through a
pull wire mechanism integrated in the handle of the catheter.
Procedure
Vital parameters such as blood pressure and oxygen saturation were
continuously monitored throughout the entire procedure. All pro-
cedures were performed under deep sedation using boluses of mida-
zolam and fentanyl as well as a continuous infusion of propofol (1%).
After placing 6 F decapolar catheters into the coronary sinus and the
His bundle region, two transseptal punctures were performed using
a modiﬁed Brockenbrough technique to introduce two 8 F sheaths
(SL1; St Jude Medical) into the LA. One puncture site in the fossa
ovalis was rather posterior, and the other more anterior. Thereafter,
heparin boluses were repeatedly administered to maintain the acti-
vated clotting time between 250 and 300 s. Selective PV angiography
was performed to identify the PV anatomy in standard angulations
(RAO 308 and LAO 408). Left-sided PVs were classiﬁed as separate
or short trunk left common PVs (LCPV), according to Marom
et al.
19 A Lasso catheter (Biosense Webster) was placed at the PV
ostium via the posterior sheath to record PV potentials (sinus
rhythm and coronary sinus pacing) using a conventional computerized
EP system (AXIOM Sensis, Siemens). The more anterior SL1 sheath
was exchanged for the 12 F transseptal sheath (FlexCath
w) in order
to introduce the cryoballoon (28 mm) catheter into the LA. Both
transseptal sheaths were constantly ﬂushed with heparinized saline
(500 IE/50 mL) (8 F: 10 mL/h and 12 F: 20 mL/h). The 28 mm balloon
was manoeuvred to all PV ostia. To assess the exact position of the
inﬂated balloon in relation to the PV–LA region, contrast medium
(Imeronw) diluted with saline 0.9% (1:1 ratio) was injected from the
distal lumen of the cryoballoon catheter.
Then, the freezing cycle (300 s) was started. Local temperature was
continuously monitored from a sensor at the proximal part of the
cryoballoon, which could only be recorded but not read out (Cryo-
console Gen 4). The PN was constantly paced (10 V, 2.9 ms) from
the superior vein cava when freezing at the RPVs. In the case of loss
of PN capture, freezing was immediately terminated. After each
freeze, PV conduction was re-evaluated by positioning the Lasso cath-
eter at the same location within the PV as before the CTE application.
Based on the angiograms, the Lasso was pulled back as proximal as
possible until it dropped into the LA after PVI to ﬁnd the site of PVI
occurrence. If the PV was not isolated, the cryoballoon was reposi-
tioned and balloon to LA–PV contact was re-evaluated by angiogra-
phy. Ablation endpoint was the loss of all PV potentials. The
position of the cryoballoon during the freeze was documented for
all applications. After a waiting period of 30 min after the last PVI, per-
sistence of the conduction block was re-checked with the Lasso cath-
eter for all veins. Thereafter, a repeat angiography was performed to
exclude PV stenosis. No intraprocedural imaging except for ﬂuoro-
scopy was used in this study. Notably, all procedures were performed
by the same investigators (K.R.J.C. and K.H.K.) with no experience with
cryoballoon technology before the study was started.
Ablation techniques
For different PVs, special ablation techniques were developed.
Left pulmonary veins
‘Crosstalk’ technique
For the left-sided PVs, cryoablation was ﬁrst deployed at the left
superior PV (LSPV) with a Lasso catheter located in the left inferior
PV (LIPV). After angiographic evaluation of PV occlusion by the
balloon, CTE was applied. Thereafter, the Lasso was placed in the
LSPV to check whether the PV was isolated or not. In the case of a
gap along the inferior aspect of the LSPV, the cryoballoon was
placed at the LIPV. After angiographic veriﬁcation of the balloon pos-
ition at the ostium of the LIPV, CTE was delivered (Figure 1A–C).
During CTE application to the LIPV, simultaneous PV recordings
from the Lasso catheter in the LSPV were obtained to assess either
LSPV spike sequence changes or LSPV isolation (Figure 1C). Because
of the interaction between the two veins, this approach has been
termed as crosstalk ablation technique. Subsequent Lasso recordings
from the LIPV documented either simultaneous PVI or guided
closure of remaining conduction gaps by further balloon applications.
Right superior pulmonary vein
‘Straightforward’ technique
The RSPV was always approached directly, and CTE was delivered after
angiographic conﬁrmation of PV occlusion. Special care was taken to
avoid PN injury by constantly pacing the PN from a catheter located in
the superior caval vein. In addition, the RSPV ostium diameter was
measured from the angiographic information (RAO 308 and LAO 408)
to allow calculation of the ratio between the size of the PV and the
size of the big balloon to assess the risk of PN injury.
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‘Direct approach’ technique
As for the superior PVs, a direct alignment of the catheter/balloon
position and the PVs was always attempted initially. However, CTE
was applied only when the cryoballoon could be positioned in such
a way that complete PV occlusion was achieved. In all other cases,
more sophisticated techniques were required.
Figure 1 The crosstalk technique: (A) big balloon ablation after occlusion of the left superior pulmonary vein (PV); the Lasso catheter is
placed in the left inferior PV. (B) Left inferior PV ablation after exchanging balloon and Lasso positions. (C) Left superior PV Lasso recordings
demonstrate remaining LA–PV conduction (arrow: PV spike, dotted line: earliest activation LSPV 15/16 indicating inferior conduction gap) and
subsequent elimination of PV spike. A, atrium; CS, coronary sinus catheter; V, ventricle; LA, left atrium; LAO, left anterior oblique; PV, pulmon-
ary vein. *Far ﬁeld atrium.
Single big cryoballoon technique 701‘Hockey stick’ technique
This strategy was used in patients with an early branching inferior PV
to allow balloon to tissue contact at the inferior PV circumference.
First, the guide wire was placed in the early branching inferior PV.
Then, the sheath was advanced with maximal bend to the superior–
posterior LA, allowing the balloon to be pushed into the inferior
part of the PV ostium, which resulted in a hockey stick conﬁguration
(Figure 2).
‘Pull-down’ technique
In patients with no or only a late branching inferior PV, the balloon was
positioned parallel to the PV ostium. If angiography indicated only a
perfect contact of the balloon at the superior circumference of the
PV but not at the lower PV circumference, freeze was started regard-
less of the remaining leakage at the inferior PV circumference
(Figure 3A). When full N2O ﬂow into the inner balloon was reached,
both the sheath and the frozen cryoballoon, which was attached to
the superior PV circumference, were then pulled down to close the
inferior gap (Figure 3B and C). Therefore, this technique was termed
pull-down technique.
The ‘big loop’ technique
This technique was used in a case with an inferior RIPV ostium, when
an early branch required for the hockey stick technique was lacking and
the pull-down technique could not be used because of a larger inferior
gap (.1 cm) (Figure 4A). To reach the PV ostium with the balloon, the
sheath was bent and directed towards the lateral posterior LA, allow-
ing the guide wire to be advanced along the posterior mitral annulus
until the distal part of the RIPV was reached. Then, the sheath was
further advanced to guide the balloon over the wire into the RIPV
ostium (Figure 4B).
Post-ablation treatment and follow-up
In all patients, pericardial effusion and pneumothorax were ruled out
(transthoracic echocardiogram and chest X-ray) after the procedure.
After ablation, patients were treated with intravenous heparin (target
PTT 50–70 s). Oralanticoagulationwasstarted the nextday. All patients
Figure 2 (A–D) The hockey stick technique: the guide wire is placed in an early branching inferior pulmonary vein (PV). The balloon is
advanced over the wire, thereby resulting in a hockey stick conﬁguration of the system. This technique enables right inferior PV (2AþB)
and left inferior PV (2CþD) isolation. Both schematic drawings (B and D) illustrate the basic principle of the hockey stick technique. CS, cor-
onary sinus catheter; LAO, left anterior oblique; LIPV, left inferior pulmonary vein; LSPV, left superior pulmonary vein; RAO, right anterior
oblique; RIPV, right inferior pulmonary vein; RSPV, right superior pulmonary vein; SVC, superior caval vein.
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months. AADtherapy wascontinued for 1 month andthen discontinued
if the patients were free of AF relapse. Follow-up included weekly tele-
phonic interviews and outpatient clinic visits at 1, 3, 6, 9, and 12
months after ablation [interview, ECG, Holter ECG, and transoesopha-
geal echocardiography (TEE)]. In addition, all patients were equipped
with a portable tele ECG device (Vitaphone, Germany) and asked to
transmit daily ECGs plus additional symptom-triggered tele ECGs for 6
months after the ablation monitored via IKKF (Institut fu ¨r klinisch-
kardiovaskula ¨re Forschung, Munich, Germany). All documented AF epi-
sodes lasting .30 s were counted as recurrences with and without a
blanking period of 3 months. In all patients, Doppler ﬂow measurement
using TEEwas performed 3 monthsafter the procedure toassesslatePV
stenosis.
20
Endpoints
The primary endpoint of the study was acute PVI. The secondary end-
points were procedure-related complications and AF recurrence.
Statistical analysis
An exploratory data analysis was performed. Data mean+standard
deviation (SD) was used to describe continuous variables with
approximately normal distribution, or the median and the 25 and
Figure 3 Pull-down technique: the balloon is positioned parallel to the pulmonary vein (PV) ostium. (A) Although angiography indicates
perfect contact of the balloon only at the superior circumference of the target PV (arrows) but not at the lower PV circumference, the
freeze is started regardless of the remaining leakage at the inferior PV circumference. (B) Both the sheath and the frozen cryoballoon attached
to the superior PV circumference are pulled down to close the inferior gap (arrows). (C) The schematic drawings illustrate the sequential steps
of the pull-down technique. CS, coronary sinus catheter; LIPV, left inferior pulmonary vein; LSPV, left superior pulmonary vein; RAO, right
anterior oblique; reference catheter, CARTO backup (Biosense Webster); RIPV, right inferior pulmonary vein; RSPV, right superior pulmonary
vein.
Single big cryoballoon technique 70375% percentiles (Q1; Q3) were presented. For categorical data, absol-
ute and relative frequencies were given. Both tables show a subset
of data of all 27 patients, including the case with the large type II
atrial septal defect (ASD), which is marked.
Results
Patients
Twenty-seven patients (19 males, mean age: 56 + 9 years) were
enrolled in the study (Table 1). Patients had a history of PAF
with a median (Q1; Q3) duration of 6.0 (3.0; 9.0) years and were
refractory to a median number (Q1; Q3) of 3 (2; 3) AADs (including
amiodarone in ﬁve patients), with a median (Q1; Q3) of 10 (8; 12)
AF episodes per month. In 9 of 27 patients, arterial hypertension
was present. In ﬁve patients, a concomitant heart disease was
present, which was a signiﬁcant type II ASD (maximum diameter
1.7 cm) in one patient (Table 1).
Procedural data
Median (Q1; Q3) procedure and ﬂuoroscopy times including PN
pace mapping were 220 min (190; 245) and 50 min (42; 69),
respectively The total balloon time (deﬁned as the time of
cryoballoon inside the LA) was 130 min (90; 170). A mean of
174 + 50 mL contrast medium was required for PV angiography.
Pulmonary vein angiography
PV angiography was used to identify PVs and to calculate mean PV
diameters. Mean PV diameter was 19 + 2 mm for LSPVs (n ¼ 18),
Figure 4 The big loop technique: (A) right inferior pulmonary vein (RIPV) with a large inferior gap (arrows) lacking an early PV branch. (B)
The sheath is directed towards the lateral posterior left atrium, allowing the guide wire to be advanced until the distal part of the RIPV is
reached. The balloon is placed over the wire at the RIPV ostium. (C) Schematic drawing of the big loop technique. CS, coronary sinus catheter;
LA, left atrium; LIPV, left inferior pulmonary vein; LSPV, left superior pulmonary vein; RAO, right anterior oblique; RIPV, right inferior pulmonary
vein; RSPV, right superior pulmonary vein; *Dislodged multipolar catheter. **Repositioned multipolar catheter for phrenic nerve stimulation.
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18 + 3 mm for RSPVs (n ¼ 27), and 20 + 4 mm for RIPVs
(n ¼ 27).
Pulmonary vein isolation
The primary endpoint of acute PVI was achieved in 98% of all PVs.
In 27 patients, a total of 99 PVs including nine LCPVs were ident-
iﬁed, all of which showed PV spikes. Ninety-seven of the 99 (98%)
PVs were electrically isolated using the single big cryoballoon tech-
nique exclusively. After the waiting time (.30 min), no PV recon-
duction was observed. All LSPVs (n ¼ 18), LIPVs (n ¼ 18), LCPVs
(n ¼ 9), and RSPVs (n ¼ 27) were successfully isolated requiring a
median (Q1; Q3) of 2 (2; 2), 2 (2; 3), 5 (4; 8), and 2 (1; 2) cryo
freezes, respectively. In 2/27 RIPVs, electrical isolation was futile,
despite a median of 3 (2; 5) freezes (Table 2). Interestingly, in
one patient (#13) with failed RIPV isolation, a pre-procedurally
diagnosed large type II ASD was present. The other patient
(# 10) with failed RIPV isolation had the smallest LA size
(30 mm) (Table 1).
Left pulmonary veins
Left superior pulmonary vein
In 18/27 patients (67%), separated left-sided PVs were identiﬁed. In
9/27 patients (33%), a short trunk LCPV was identiﬁed. In 17/18
patients (94%) with separated LPVs, complete LSPV occlusion
was achieved, resulting in subsequent PVI. In the remaining 10
patients (one separated LPV and nine LCPVs), freezing at the
LSPV branch did not isolate the LSPV, but isolation was achieved
in all cases using the crosstalk technique.
Left inferior pulmonary vein (cross)
In 22/27 patients (81%), complete LIPV occlusion was achieved,
resulting in PVI. In 5/27 patients (19%), an inferior contrast
leakage was present, which was closed using either the pull-down
(n ¼ 3) or the hockey stick technique (n ¼ 2).
Right pulmonary veins
Right superior pulmonary vein
In 27/27 patients (100%), complete RSPV occlusion was achieved
(‘straightforward’ approach), resulting in subsequent PVI.
...............................................................................................................................................................................
Table 1 Patients demographics
Patient
no.
Gender Age
(years)
Concomitant heart
disease
LA size
(mm)
Duration of PAF
(years)
Number of PAF episodes
before PVI per months
Number of failed
AAD
1 M 64 None 42 8 8 2
2 M 62 None 37 30 15 3
3 M 55 HTN 45 7 4 3
4 M 49 HTN 39 5 3 3
5 M 55 None 32 6 12 2
6 M 59 HTN, CAD 49 3 2 2
7 F 41 None 40 4 10 3
8 F 58 HTN 42 10 10 3
9 F 76 None 39 7 8 5
10 F 59 None 30 2 12 2
11 F 45 None 36 7 12 2
12 M 46 None 45 3 10 2
13 F 58 HTN, ASD II 50 8 10 3
14 M 44 None 39 10 30 3
15 M 47 None 41 3 6 3
16 F 64 HTN 43 11 8 3
17 M 62 HTN 43 9 3 2
18 M 49 None 42 2 12 2
19 M 63 HTN, CAD 43 2 3 4
20 M 55 DCM 43 3 10 2
21 M 44 None 41 8 30 3
22 M 41 None 33 11 30 3
23 M 66 None 49 2 10 3
24 F 62 HTN, MI 51 1 30 2
25 M 63 HTN 40 10 10 3
26 M 67 None 44 2 10 3
27 M 35 None 44 5 10 3
AAD, anti-arrhythmic drugs; ASD, atrial septal defect; CAD, coronary artery disease; DCM, dilative cardiomyopathy; F, female; HTN, hypertension; LA, left atrium; M, male; PAF,
paroxysmal atrial ﬁbrillation; PVI, pulmonary vein isolation.
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Twenty-ﬁve of 27 RIPVs were successfully isolated. In two of 27
patients (7%) (#10 and #13), no RIPV isolation was achieved. In
ﬁve of 27 patients (19%), complete RIPV occlusion was achieved
using the ‘direct approach’ resulting in PVI, whereas in 20 of 27
patients (74%), either the pull-down (n ¼ 15), the hockey stick
(n ¼ 4) or the big loop technique (n ¼ 1) was used to achieve PVI.
Procedural complications
Complications as a secondary endpoint occurred in 3/27 patients
(11%).Despitecontinuousright-sidedPNstimulationduringablation
oftheseptalPVs,onePNPoccurredafteranunanticipatedfreezeina
distal position inside the RSPV: during freezing, the balloon pressure
decreased,whichleadtoamoredistalballoonposition(patient#16,
PVsize:18.2 mm)(Figure5).TwoadditionalPNlesionsoccurred:one
during freezing from the RSPV (Patient 18, PV size: 26.0 mm) and the
other from the RIPV (Patient 24, PV size: 26.0 mm). The ratio of PV
size(26 mm)toballoonsize(28 mm)withPNdamagewas0.93.CTE
application was immediately terminated if PN capture was lost
(Patient 16, duration: 120 s; Patient 18, duration: 223 s; Patient 24,
duration: 59 s). The PN function recovered in Patient 24 during the
procedure after 3 min (freeze at RIPV). In the remaining patients,
the PNP persisted until the end of the procedure. No further com-
plications including PV stenosis were observed.
Follow-up
AF recurrence deﬁned as a secondary endpoint was observed in 8/
27 patients (30%) during a median (Q1; Q3) follow up of 271 days
(147; 356) with a blanking period of 3 months and in 13/27 patients
(48%) without the blanking period. Interestingly, only AF, but no
atrial tachycardia (AT), was observed during follow-up. Stable
sinus rhythm was documented throughout the follow-up period
in 19/27 patients (70%, 3-month blanking period) and in 14/27
patients (52%, no blanking period). In none of the patients, an
......................................................
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Table 2 Ablation details, ablation techniques, and success rates of acute electrical pulmonary vein isolation using the
single big cryoballoon technique
Patient no. Balloon
size (mm)
No. of cryo-freezes PV isolation (%) Special ablation
technique (s)
LSPV LCPV LIPV RSPV RIPV
1 28 7 2 3 100 LCPV: crosstalk RIPV; hockey stick
2 28 2 4 1 1 100 RIPV: pull-down
3 2 8 1 1121 0 0
4 28 3 4 2 100 LCPV: crosstalk; LIPV: pull-down
5 28 3 5 4 2 100 RIPV: pull-down; LIPV: hockey stick
6 28 2 2 2 3 100 RIPV: pull-down
7 28 2 2 2 8 100 RIPV: hockey stick
8 2 8 1 2221 0 0
9 28 2 2 2 100 LCPV: crosstalk
10 28 1 3 2 6 75
11 28 5 2 5 100 LCPV: crosstalk; RIPV: pull-down
12 28 1 2 1 3 100 RIPV: pull-down
13 28 13 4 5 67 LCPV: crosstalk
14 28 5 2 2 100 LCPV: crosstalk; RIPV: pull-down
15 28 2 2 2 8 100 RIPV: hockey stick
16 28 8 1 7 100 LCPV: crosstalk; RIPV: pull-down; LIPV: hockey stick
17 28 3 6 1 3 100 LSPV: crosstalk; RIPV: hockey stick
18 28 2 2 1 1 100
19 28 4 1 9 100 LCPV: crosstalk; RIPV: pull-down; LIPV: pull-down
20 28 4 1 5 100 LCPV: crosstalk; RIPV: pull-down; LIPV: pull-down
21 28 2 3 1 8 100 RIPV: pull-down
22 28 2 2 3 3 100 RIPV: pull-down
23 28 3 2 1 3 100 RIPV: pull-down
24 28 2 2 1 3 100 RIPV: pull-down
25 28 2 3 3 4 100 RIPV: pull-down
26 28 2 2 1 1 100 RIPV: pull-down
27 28 2 2 2 2 100 RIPV: big loop
Median (Q1; Q3) 2 (2; 2) 5 (4; 8) 2 (2; 3) 2 (1; 2) 3 (2; 5) 98.0+8%
PV, pulmonary vein; LCPV, left common pulmonary vein; LIPV, left inferior pulmonary vein; LSPV, left superior pulmonary vein; RIPV, right inferior pulmonary vein; RSPV, right
superior pulmonary vein.
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3-month TEE.
In both patients with PNP at the end of the ablation procedure,
the PN function has recovered within 28 days (Patient 18) and 384
days (Patient 16) of follow-up, respectively.
Discussion
Catheter ablation using RFC energy has been established as a curative
treatment in patients with PAF.
21 However, the creation of point by
point RFC energy linear lesions requires the understanding of the
individual LA anatomy, including the identiﬁcation of the PV
ostia,
3,22 and may be associated with signiﬁcant procedure-related
complications.
4–7In contrast, CTE balloon-based ablation is designed
to achieve complete circular lesions around the pulmonary veins,
independent of the individual PV anatomy. Therefore, this novel
ablation technology may facilitate PVI and improve the safety of the
procedure.
Successful PVI using CTE delivered via a balloon approach
requires perfect contact to the LA wall around the PVs. Incomplete
contact would result in conduction gaps and prevent complete PVI.
Complete contact can be rather easily achieved with small
balloons, but they would isolate distal PV sites instead of the
antrum. Importantly, the antrum has been shown to be not only
responsible for AF initiation but also for AF maintenance.
23,24
Furthermore, a distal balloon ablation in the septal PVs would
particularly increase the risk of PNP.
18
Therefore, in this study, we investigated the hypothesis of
whether acute PVI of all PVs can be achieved using CTE and a
single big balloon in consecutive patients without any prior or
intraprocedural LA imaging except angiography. We tested this
in the patient population with PAF, because it has been shown
that PVI at the antrum level is highly effective.
3,25
In this study, we have demonstrated that 98% ofall PVscan be iso-
lated using the single big cryoballoon technique only. No additional
balloon sizes or catheter-based ‘touch-up’ freezes were used.
In this consecutive series of patients, only two RIPVs could not
be isolated. It is well known that the RIPV is the most difﬁcult PV to
reach after transseptal puncture. Balloon positioning in the RIPV
requires postero-inferior rotation of the whole sheath/balloon
system. In a previous study analysing LA MRI data, the mean endo-
luminal distance from the fossa ovalis to the RIPV was 20.2 mm,
26
explaining the difﬁculty in achieving stable contact and failure of
RIPV isolation in the patient with the smallest LA diameter
(30 mm). Interestingly, this patient still has remained free of AF epi-
sodes, which is in agreement with the observation that the RIPV is
the least electrically active PV.
27 In the second patient, the trans-
septal sheath and the balloon could not be stably positioned in
the RIPV ostium due to a large type II ASD (1.7 cm).
To obtain PVI with the single big cryoballoon technique, differ-
ent procedural approaches were developed. First, approaching the
superior PVs was mostly straightforward as the superior PVs are in
direct alignment with the catheter/balloon position following trans-
septal puncture. Therefore, a median (Q1; Q2) of only 2 (2; 2) and 2
(1; 2) freezes (RSPV and LSPV) was necessary to obtain PVI. Due
to signiﬁcant overlap of the big balloon with the ostia of the lateral
Figure 5 Phrenic nerve lesion: (A) baseline angiography of right
superior pulmonary vein (RSPV) in right anterior oblique. (B)O s t i a l
balloonposition atthestartofthe freeze.(C) Unanticipated cryobal-
loon ablation inside the RSPV. CS, coronary sinus catheter; PN stim,
phrenic nerve stimulation; RAO, right anterior oblique; RSPV, right
superior pulmonary vein; RIPV, right inferior pulmonary vein.
Single big cryoballoon technique 707veins, ﬁnal PVI of the LSPV was usually achieved from the inferior
PV after a ﬁrst freeze was applied to the superior vein (crosstalk
technique). This prevented multiple unnecessary applications to
the LSPV for complete PVI. The inferior PVs, particularly the
RIPV, were more difﬁcult to isolate and required the development
of a variety of ablation techniques depending on patients individual
anatomy.
Side effects of cryothermal ablation using
the single big cryoballoon technique
Phrenic nerve injury
PN injury is a rare (,1%) but severe complication when RFC
energy is deployed at the RSPV.
28 This complication is signiﬁcantly
higher (up to 10%) when balloon-based ablation strategies are
used.
15,17,29 Particularly, small balloons located inside the PVs
may lead to a short distance to the PN and increased risk of PN
injury.
18,30 In our study, the single big cryoballoon strategy uses
an intentionally oversized balloon covering the proximal LA
antrum region with as much distance to the PN as possible. This
explains why no PN palsies occurred as long as ablation inside
the PVs was avoided. However, if CTE was unintentionally
deployed inside the septal PVs, PNP also occurred, which was
short-lasting (Patient 18: 28 days and Patient 24: 3 min) after freez-
ing at two large septal PVs (RSPV and RIPV: both 26 mm) and long-
lasting (Patient 16: 384 days) after freezing inside an RSPV (Patient
16, PV: 18.2 mm). These ﬁndings prove our concept that distal
balloon ablation at the septal PVs must be avoided and emphasizes
the need for a .28 mm cryoballoon for larger veins. The calcu-
lated ratio between PV and balloon sizes indicates that a ratio
 0.93 should not lead to CTE balloon ablation since even with
the 28 mm cryoballoon distal balloon positions and subsequent
PNP cannot be avoided in all patients.
Cryothermal lesions
The primary endpoint of acute electrical PVI was achieved in
almost all PVs. This study did not assess permanent PVI. The
chronic course of CTE balloon lesions is not known. A previous
study in patients with atrial ﬂutter demonstrated permanent bidir-
ectional block at the right atrial isthmus.
31 However, several
studies using CTE for catheter ablation of accessory pathways
mediated tachycardias, and atrioventricular nodal re-entry tachy-
cardias have shown a higher recurrence rate than with RFC.
9,10
AF recurrences in this series may indicate recovered PV conduc-
tion. The relatively high recurrence rate (48%) compared with
studies using RFC energy is biased by the fact that daily ECG
recordings were also obtained within the ﬁrst 3 months, a time
that is generally not taken into consideration (blanking period).
Applying a blanking period of 3 months, the rate of AF recurrences
decreased (30%). Nevertheless, the chronic lesion assessment
after big cryoballoon-induced PVI is mandatory in future studies.
Interestingly, only AF recurrence, but not AT, has been observed.
Whether this indicates rather large conduction gaps remains
speculative.
Two interesting acute observations during CTE balloon ablation
were made. First, the crosstalk phenomenon at the lateral PVs indi-
cates that lesions were set at the LA antrum level with the poten-
tial limitation of a less chronic effect due to the thickness of the
myocardium at this site. Secondly, acute PVI does not necessarily
require complete PV occlusion at the initial balloon position, but
may be achieved in a stepwise approach as demonstrated by the
pull-down technique. This makes electrical isolation of the inferior
PVs feasible using the big balloon technique.
Procedural costs
In the light of limited ﬁnancial resources in many countries and the
large number of patients with PAF, a simpliﬁed ablation strategy for
PVI is desirable. The results of this study using only one single big
balloon without the need for pre- or intraprocedural LA imaging
could make such a strategy also attractive from an economic
standpoint.
Limitations
In this study, only a rather small number of patients with paroxys-
mal AF have been studied. Nevertheless, we believe that the
results for acute PVI are representative for this patient population
and that PVI can be achieved in almost all patients. Identiﬁcation of
the site of PVI is limited to the fact that no three-dimensional
reconstruction was performed at the end of the procedure. We
do not know whether large common ostia can be isolated
because these patients were not part of this study. Larger
balloon sizes (.28 mm) would be necessary to successfully
approach such an anatomy. Furthermore, daily ECG monitoring
was only performed over the ﬁrst 6 months after the procedure,
followed by 24 h Holter monitoring at 9 and 12 months. There-
fore, we do not know whether daily monitoring over 12 months
would have changed the number of AF recurrences. Further
studies will be required in larger patient populations to assess
the incidence of permanent PVI and its effect on clinical
outcome. Furthermore, it needs to be proven in larger series
whether the suggested ratio between PV and balloon sizes
( 0.93) may be valuable to estimate the risk of PNP and
whether an even bigger balloon could further reduce the risk of
PNP. In addition, randomized studies comparing cryoballoon
ablation with conventional RFC energy will be necessary to
assess efﬁcacy, complications, and cost-efﬁcacy.
Conclusion
Using the single big cryoballoon technique, almost all PVs (98%)
could be electrically isolated without LA imaging and may reduce
the incidence of PNP as long as distal ablation inside the septal
PVs is avoided.
Funding
Funding to pay the Open Access publication charges for this article was
provided by ASKLEPIOS proresearch (Hamburg, Germany).
Conﬂict of interest: K.-R.J.C. and K.H.K. received educational honor-
aria from Cryocath.
References
1. Haissaguerre M, Shah DC, Jais P, Hocini M, Yamane T, Deisenhofer I, Chauvin M,
Garrigue S, Clementy J. Electrophysiological breakthroughs from the left atrium
to the pulmonary veins. Circulation 2000;14:2463–2465.
K.-R.J. Chun et al. 7082. Oral H, Scharf C, Chugh A, Hall B, Cheung P, Good E, Veerareddy S, Pelosi F Jr,
Morady F. Catheter ablation for paroxysmal atrial ﬁbrillation: segmental pulmon-
ary vein ostial ablation versus left atrial ablation. Circulation 2003;108:2355–2360.
3. Ouyang F, Bansch D, Ernst S, Schaumann A, Hachiya H, Chen M, Chun J, Falk P,
Khanedani A, Antz M, Kuck KH. Complete isolation of left atrium surrounding the
pulmonary veins: new insights from the double-Lasso technique in paroxysmal
atrial ﬁbrillation. Circulation 2004;110:2090–2096.
4. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G,
Packer D, Skanes A. Worldwide survey on the methods, efﬁcacy, and safety of
catheter ablation for human atrial ﬁbrillation. Circulation 2005;111:1100–1105.
5. Epstein MR, Knapp LD, Martindill M, Lulu JA, Triedmann JK, Calkins H, Huang SK,
Walsh EP, Saul JP. Embolic complications associated with radiofrequency catheter
ablation. Atakr Investigator Group. Am J Cardiol 1996;77:655–658.
6. Pappone C, Oral H, Santinelli V, Vicedomini G, Lang CC, Manguso F, Torracca L,
Benussi S, Alﬁeri O, Hong R, Lau W, Hirata K, Shikuma N, Hall B, Morady F.
Atrio-esophageal ﬁstula as a complication of percutaneous transcatheter ablation
of atrial ﬁbrillation. Circulation 2004;109:2724–2726.
7. Robbins IM, Colvin EV, Doyle TP, Kemp WE, Loyd JE, McMahon WS, Kay GN.
Pulmonary vein stenosis after catheter ablation of atrial ﬁbrillation. Circulation
1998;98:1769–1775.
8. Schmidt B, Antz M, Ernst S, Ouyang F, Falk P, Chun JK, Kuck KH. Pulmonary vein
isolation by high-intensity focused ultrasound: ﬁrst-in-man study with a steerable
balloon catheter. Heart Rhythm 2007;4:575–584.
9. Zrenner B, Dong J, Schreieck J, Deisenhofer I, Estner H, Luani B, Karch M,
Schmitt C. Transvenous cryoablation versus radiofrequency ablation of the
slow pathway for the treatment of atrioventricular nodal re-entrant tachycardia:
a prospective randomized pilot study. Eur Heart J 2004;25:2226–2231.
10. Friedman PL, Dubuc M, Green MS, Jackman WM, Keane DT, Marinchak RA,
Nazari J, Packer DL, Skanes A, Steinberg JS, Stevenson WG, Tchou PJ,
Wilber DJ, Worley SJ. Catheter cryoablation of supraventricular tachycardia:
results of the multicenter prospective ‘frosty’ trial. Heart Rhythm 2004;1:129–138.
11. Tse HF, Reek S, Timmermans C, Lee KL, Geller JC, Rodriguez LM, Ghaye B,
Ayers GM, Crijns HJ, Klein HU, Lau CP. Pulmonary vein isolation using transve-
nous catheter cryoablation for treatment of atrial ﬁbrillation without risk of pul-
monary vein stenosis. J Am Coll Cardiol 2003;42:752–758.
12. Khairy P, Chauvet P, Lehmann J, Lambert J, Macle L, Tanguay JF, Sirois MG,
Santoianni D, Dubuc M. Lower incidence of thrombus formation with cryoenergy
versus radiofrequency catheter ablation. Circulation 2003;107:2045–2050.
13. Sarabanda AV, Bunch TJ, Johnson SB, Mahapatra S, Milton MA, Leite LR,
Bruce GK, Packer DL. Efﬁcacy and safety of circumferential pulmonary vein iso-
lation using a novel cryothermal balloon ablation system. J Am Coll Cardiol 2005;
46:1902–1912.
14. van Oeveren W, Crijns HJ, Korteling BJ, Wegereef EW, Haan J, Tigchelaar I,
Hoekstra A. Blood damage, platelet and clotting activation during application of
radiofrequency or cryoablation catheters: a comparative in vitro study. J Med
Eng Technol 1999;23:20–25.
15. Reddy VY, Neuzil P, Pitschner HF, Kuniss M, Kralovec S, Kanova M, Laragy,
Mihalik TA, Taborsky M, Ruskin JN. Clinical experience with a balloon cryoabla-
tion catheter for pulmonary vein isolation in patients with atrial ﬁbrillation:
one-year results. Circulation 2005;Suppl II:112, Abstract 2630.
16. Pitschner HF, Reddy V, Kuniss M, Neuzil P, Laragy M, Taborsky M, Ruskin J,
Hamm C. Pulmonary vein isolation in patients with atrial ﬁbrillation using a
novel balloon cryoablation catheter. Eur Heart J 2005;(Suppl):131, Abstract 961.
17. Van Belle Y, Janse P, Rivero-Ayerza MJ, Thornton AS, Jessurun ER, Theuns D,
Jordaens L. Pulmonary vein isolation using an occluding cryoballoon for circum-
ferential ablation: feasibility, complications, and short-term outcome. Eur Heart J
2007;28:2231–2237.
18. Neumann T, Vogt J, Schumacher B, Dorszewski A, Kuniss M, Neuser H,
Kurzidim K, Berkowitsch A, Koller M, Heintze J, Scholz U, Wetzel U,
Schneider MA, Horstkotte D, Hamm CW, Pitschner HF. Circumferential pulmon-
ary vein isolation with the cryoballoon technique results from a prospective
3-center study. J Am Coll Cardiol 2008;52:273–278.
19. Marom EM, Herndon JE, Kim YH, McAdams HP. Variations in pulmonary venous
drainage to the left atrium: implications for radiofrequency ablation. Radiology
2004;230:824–829.
20. Schneider C, Ernst S, Bahlmann E, Malisius R, Krumsdorf U, Boczor S, Lampe F,
Hoffmann-Riem M, Kuck KH, Antz M. Transesophageal echocardiography: a
screening method for pulmonary vein stenosis after catheter ablation of atrial
ﬁbrillation. Eur J Echocardiogr 2006;7:447–456.
21. Natale A, Raviele A, Arentz T, Calkins H, Chen SA, Haı ¨ssaguerre M, Hindricks G,
Ho Y, Kuck KH, Marchlinski F, Napolitano C, Packer D, Pappone C,
Prystowsky EN, Schilling R, Shah D, Themistoclakis S, Verma A. Venice Chart
international consensus document on atrial ﬁbrillation ablation. J Cardiovasc Elec-
trophysiol 2007;18:560–580.
22. Marrouche NF, Martin DO, Wazni O, Gillinov AM, Klein A, Bhargava M, Saad E,
Bash D, Yamada H, Jaber W, Schweikert R, Tchou P, Abdul-Karim A, Saliba W,
Natale A. Phased-array intracardiac echocardiography monitoring during pulmon-
ary vein isolation in patients with atrial ﬁbrillation: impact on outcome and com-
plications. Circulation 2003;107:2710–2716.
23. Ouyang F, Ernst S, Chun J, Ba ¨nsch D, Li Y, Schaumann A, Mavrakis H, Liu X,
Deger FT, Schmidt B, Xue Y, Cao J, Hennig D, Huang H, Kuck KH, Antz M. Elec-
trophysiological ﬁndings during ablation of persistent atrial ﬁbrillation with elec-
troanatomic mapping and double Lasso catheter technique. Circulation 2005;
112:3038–3048.
24. Haı ¨ssaguerre M, Sanders P, Hocini M, Hsu LF, Shah DC, Scave ´e C, Takahashi Y,
Rotter M, Pasquie ´ JL, Garrigue S, Cle ´menty J, Jaı ¨s P. Changes in atrial ﬁbrillation
cycle length and inducibility during catheter ablation and their relation to
outcome. Circulation 2004;109:3007–3013.
25. Ouyang F, Antz M, Ernst S, Hachiya H, Mavrakis H, Deger FT, Schaumann A,
Chun J, Falk P, Hennig D, Liu X, Bansch D, Kuck KH. Recovered pulmonary
vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after
complete circular isolation of the pulmonary veins: lessons from double Lasso
technique. Circulation 2005;111:127–135.
26. Schmidt B, Ernst S, Ouyang F, Chun KR, Broemel T, Bansch D, Kuck KH, Antz M.
External and endoluminal analysis of left atrial anatomy and the pulmonary veins
in three-dimensional reconstructions of magnetic resonance angiography: the full
insight from inside. J Cardiovasc Electrophysiol 2006;17:957–964.
27. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S,
Le Mouroux A, Le Metayer P, Clementy J. Spontaneous initiation of atrial ﬁbrilla-
tion by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:
659–666.
28. Lee BK, Choi KJ, Kim J, Rhee KS, Nam GB, Kim YH. Right phrenic nerve injury
following electrical disconnection of the right superior pulmonary vein. Pacing
Clin Electrophysiol 2004;27:1444–1446.
29. Antz M, Chun KR, Ouyang F, Kuck KH. Ablation of atrial ﬁbrillation in humans
using a balloon-based ablation system: identiﬁcation of the site of phrenic nerve
damage using pacing maneuvers and CARTO. J Cardiovasc Electrophysiol 2006;
17:1242–1245.
30. Sanchez-Quintana D, Cabrera JA, Climent V, Farre J, Weiglein A, Ho SY. How
close are the phrenic nerves to cardiac structures? Implications for cardiac inter-
ventionalists. J Cardiovasc Electrophysiol 2005;16:309–313.
31. Manusama R, Timmermans C, Limon F, Philippens S, Crijns HJ, Rodriguez LM.
Catheter-based cryoablation permanently cures patients with common atrial
ﬂutter. Circulation 2004;109:1636–1639.
Single big cryoballoon technique 709